Phase IIA Study in Patients With Schizophrenia

Comparison of Intramuscular Olanzapine Depot With Placebo in the Treatment of Patients With Schizophrenia

NCT00088478 ·Status: COMPLETED ·Phase: PHASE3

Study Evaluating SCA-136 in Subjects With Acute Exacerbations of Schizophrenia

NCT00265551 ·Status: COMPLETED ·Phase: PHASE2

6-Month Extension Trial of Asenapine With Olanzapine in Negative Symptom Patients Who Completed the Protocol 25543 (25544)(P05777)

NCT00265343 ·Status: COMPLETED ·Phase: PHASE3

Olanzapine Versus Placebo in the Treatment of Adolescents With Schizophrenia

NCT00051298 ·Status: COMPLETED ·Phase: PHASE3

SB-773812 Administered In Adults With Schizophrenia

NCT00259870 ·Status: COMPLETED ·Phase: PHASE2

A Study to Test the Safety and Efficacy of MK-8998 in Acutely Psychotic Participants With Schizophrenia (MK-8998-004)

NCT00827918 ·Status: COMPLETED ·Phase: PHASE2

A Randomized, Double-Blind, Placebo-Controlled Study With an Open-Label, Long-Term Safety Phase to Evaluate the Efficacy and Safety of TV-44749 in Adults With Schizophrenia

NCT05693935 ·Status: COMPLETED ·Phase: PHASE3

Clinical Trial of Dipyridamole in Schizophrenia

NCT00349973 ·Status: COMPLETED ·Phase: NA

Long-acting Paliperidone Palmitate Injection and Olanzapine for Schizophrenia

NCT02918825 ·Status: COMPLETED ·Phase: NA

Efficacy and Safety of Asenapine Compared With Olanzapine in Patients With Persistent Negative Symptoms of Schizophrenia (25543)(COMPLETED)(P05817)

NCT00212836 ·Status: COMPLETED ·Phase: PHASE3

Evaluation of the Necessity of Long-term Pharmacological Treatment With Antipsychotics in Schizophrenic Patients

NCT02307396 ·Status: COMPLETED ·Phase: PHASE4

A Study to Investigate the Efficacy, Safety and Tolerability of Four Different Doses of BI 409306 Compared to Placebo Given for 12 Weeks in Patients With Schizophrenia on Stable Antipsychotic Treatment.

NCT02281773 ·Status: COMPLETED ·Phase: PHASE2

Olanzapine Versus An Active Comparator in the Treatment of Schizophrenia

NCT00036088 ·Status: COMPLETED ·Phase: PHASE4

A Combination of Two Currently Approved Drugs to Enhance the Treatment of Schizophrenia

NCT00089869 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Efficacy & Safety of SCH 900435 in Schizophrenia (Study P06079)(WITHDRAWN)

NCT00988728 ·Status: WITHDRAWN ·Phase: PHASE2

Olanzapine Versus Active Comparator in the Treatment of Depression in Patients With Schizophrenia

NCT00034801 ·Status: COMPLETED ·Phase: PHASE4

Study of Olanzapine vs. Aripiprazole in the Treatment of Schizophrenia

NCT00088049 ·Status: COMPLETED ·Phase: PHASE4

Fixed Dose Efficacy and Safety Study of Asenapine for the Treatment of Schizophrenia in Adolescents (P05896)

NCT01190254 ·Status: COMPLETED ·Phase: PHASE3

Randomized, Double-blinded, Placebo-controlled, Evaluating the Treatment With LB-102 in Patients With Acute Schizophrenia

NCT06179108 ·Status: COMPLETED ·Phase: PHASE2

This Study Tests Whether BI 409306 Prevents Patients With Schizophrenia From Becoming Worse. This Study Looks at How Well Patients Tolerate BI 409306 and How Effective it is Over 6 Months

NCT03351244 ·Status: TERMINATED ·Phase: PHASE2

A Study Comparing Rapid Acting Intramuscular Olanzapine and Placebo in Agitated Patients With Schizophrenia

NCT00640510 ·Status: COMPLETED ·Phase: PHASE3

Trial Evaluating Three Fixed Doses of Paliperidone Extended-Release (ER) Tablets and Olanzapine in the Treatment of Patients With Schizophrenia

NCT00083668 ·Status: COMPLETED ·Phase: PHASE3

Open-label Trial Characterizing the PK of 3 SC Olanzapine Extended-release Formulations in Participants With Schizophrenia/Schizoaffective Disorder

NCT06319170 ·Status: COMPLETED ·Phase: PHASE1

Efficacy and Safety of Asenapine With Placebo and Olanzapine (41021)(P05933)

NCT00156117 ·Status: COMPLETED ·Phase: PHASE3

Trial Evaluating Three Fixed Dosages of Paliperidone Extended-Release (ER) Tablets and Olanzapine in the Treatment of Patients With Schizophrenia

NCT00078039 ·Status: COMPLETED ·Phase: PHASE3